Furthermore, we have recently reported that adoptively transferred tumor-specific CX3CR1−CD8+ T cells generate CX3CR1+ CD8+ T cells upon in vivo stimulation, traffic to the TME, and mediate effective regression of established tumors43. The gene discussed is CX3CR1; the disease is neoplasm.